Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Chai Ni Chang"'
Autor:
Stephanie Manson, Fritz Offner, Ira Gupta, Ann Janssens, Peter Hillmen, Chai-Ni Chang, Janusz Kloczko, K Govind Babu, Sebastian Grosicki, Astrid McKeown
Publikováno v:
Acta Oncologica. 55:1115-1120
Patients diagnosed with chronic lymphocytic leukemia (CLL) are usually elderly and frequently have a number of comorbidities. Health-related quality of life (HRQoL) for these patients is of utmost importance and should be taken into consideration whe
Autor:
Chai-Ni Chang, Sebastian Grosicki, Ira Gupta, Lukas Smolej, Ann Janssens, Kazimierz Kuliczkowski, Sarah L. West, Oliver Wright, Michael Doubek, Wojciech Homenda, Natalia Domnikova, Panayiotis Panayiotidis, Fritz Offner, Ian W. Flinn, Boris V. Afanasyev, Alison M. Barker
Publikováno v:
American Journal of Hematology. 91:900-906
The purpose of this study is to assess the safety and efficacy of the combination of ofatumumab and bendamustine in patients with previously untreated or relapsed chronic lymphocytic leukemia. Patients received IV ofatumumab (cycle 1: 300 mg day 1 an
Autor:
Fritz Offner, Sebastian Grosicki, Iestyn Dixon, Panagiotis Panagiotidis, Anna Schuh, Chai-Ni Chang, Peter Hillmen, Andrew R. Pettitt, K Govind Babu, Eva Kimby, Tadeusz Robak, Michael Doubek, Marco Montillo, Jodi L Carey, Steen Lisby, Thomas E. Boyd, Janusz Kloczko, Ira Gupta, Ann Janssens, Oliver Wright, Astrid McKeown
Publikováno v:
The Lancet. 385:1873-1883
Treatment for patients with chronic lymphocytic leukaemia who are elderly or who have comorbidities is challenging because fludarabine-based chemoimmunotherapies are mostly not suitable. Chlorambucil remains the standard of care in many countries. We
Autor:
K Govind Babu, Sebastian Grosicki, Yaroslav Kulyaba, Steen Lisby, Javier Loscertales, Tadeusz Robak, Grygoriy Rekhtman, Iryna Kryachok, Jerzy Z. Blonski, Krzysztof Warzocha, Kazimierz Kuliczkowski, Astrid McKeown, Wojciech Homenda, V Bal, Kudrat Abdulkadyrov, Chai-Ni Chang, Janusz Kloczko, Ira Gupta
Publikováno v:
Leukemialymphoma. 58(7)
Chronic lymphocytic leukemia (CLL) is an incurable disease. Quality of life during treatment and periods of subsequent remission is therefore vital. Health-related quality of life (HRQoL) was compared in relapsed CLL during and after treatment with o
Autor:
Ira Gupta, K Govind Babu, Javier Loscertales, Sebastian Grosicki, Grygoriy Rekhtman, Kudrat Abdulkadyrov, Tadeusz Robak, Jerzy Z. Blonski, Chai-Ni Chang, Iryna Kryachok, Michele Gorczyca, Kazimierz Kuliczkowski, Astrid McKeown, Yaroslav Kulyaba, Steen Lisby, Krzysztof Warzocha, Janusz Kloczko, Wojciech Homenda, Jodi L Carey
Publikováno v:
Leukemialymphoma. 58(5)
In this multicenter, open-label, phase III study, patients with relapsed chronic lymphocytic leukemia (CLL) were randomized (1:1) to receive ofatumumab plus fludarabine and cyclophosphamide (OFA + FC) or FC alone; the primary endpoint being progressi
Autor:
Ian W, Flinn, Panayiotis, Panayiotidis, Boris, Afanasyev, Ann, Janssens, Sebastian, Grosicki, Wojciech, Homenda, Lukas, Smolej, Kazimierz, Kuliczkowski, Michael, Doubek, Natalia, Domnikova, Sarah L, West, Chai-Ni, Chang, Alison M, Barker, Ira V, Gupta, Oliver J, Wright, Fritz, Offner
Publikováno v:
American journal of hematology. 91(9)
The purpose of this study is to assess the safety and efficacy of the combination of ofatumumab and bendamustine in patients with previously untreated or relapsed chronic lymphocytic leukemia. Patients received IV ofatumumab (cycle 1: 300 mg day 1 an
Autor:
Jan Moritz Middeke, Andrey Zaritskey, Anders Österborg, Michele Gorczyca, Anna Schuh, Ira Gupta, Grzegorz Mazur, Yaroslav Kulyaba, Steen Lisby, Miklós Udvardy, Michael Steurer, Per Andersson, Chai Ni Chang, Sebastian Grosicki, Marco Montillo, Polina Kaplan, Iryna Kryachok, Siobhan Daly, Grygoriy Rekhtman
Publikováno v:
Leukemialymphoma. 57(9)
We report results of a randomized, phase III study of ofatumumab versus physicians' choice treatment in patients with bulky fludarabine-refractory chronic lymphocytic leukemia and explore extended versus standard-length ofatumumab treatment. Patients
Autor:
Julie C. Yates, Donald H. Horstman, Tushar Shah, Tracy Fischer, Donald A. Mahler, Chai-Ni Chang, Patrick Wire
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 166:1084-1091
This randomized controlled trial examined the benefits of combining an inhaled corticosteroid, fluticasone propionate (F), with an inhaled long-acting beta(2)-agonist, salmeterol (S), to treat the inflammatory and bronchoconstrictive components of ch
Autor:
Eva Kimby, Marco Montillo, Peter Hillmen, Astrid McKeown, Sebastian Grosicki, Tadeusz Robak, Thomas E. Boyd, Ira Gupta, Ann Janssens, Anna Schuh, Chai-Ni Chang, Panagiotis Panagiotidis, Jiri Mayer, Steen Lisby, K. Govindbabu, Jodi L Carey, Fritz Offner
Publikováno v:
Blood. 122:528-528
Introduction Chemoimmunotherapy with purine analogues and the anti-CD20 antibody rituximab is the standard of care as initial therapy in younger and physically fit patients with chronic lymphocytic leukemia (CLL). However, most CLL patients are elder
Autor:
Österborg, Anders, Udvardy, Miklós *, Zaritskey, Andrey *, Andersson, Per-Ola *, Grosicki, Sebastian *, Mazur, Grzegorz *, Kaplan, Polina *, Steurer, Michael *, Schuh, Anna *, Montillo, Marco *, Kryachok, Iryna, Middeke, Jan Moritz *, Kulyaba, Yaroslav *, Rekhtman, Grygoriy *, Gorczyca, Michele *, Daly, Siobhan *, Chai-Ni, Chang *, Lisby, Steen *, Gupta, Ira *
Publikováno v:
In Blood 6 December 2014 124(21):4684-4684